Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cell Therapeutics completes Zevalin's acquisition for U.S. sales and marketing

Dec. 31, 2007

Phase I trial commences for Cougar Biotechnology's CB-3304

Dec. 31, 2007

Progen's phase III study of PI-88 for HCC open for recruitment

Dec. 31, 2007

Phase II IPI-504 trial initiated in patients with non-small cell lung cancer

Dec. 28, 2007

Peregrine gives update on its three lead clinical programs for bavituximab and Cotara

Dec. 28, 2007

Tissue-specific FAK gene deletion blocks mammary tumor progression

Dec. 28, 2007

Preliminary phase I results with AT-9283 in hematological malignancies encouraging

Dec. 28, 2007

Activity seen with SNS-595 in acute leukemia patients

Dec. 28, 2007

Phase I/II study of Oncohist in leukemia progresses

Dec. 28, 2007

Millennium submits supplemental NDA to FDA for Velcade for multiple myeloma

Dec. 27, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...